The global myomectomy industry was valued at USD 642.1 million in 2024 and is projected to reach USD 1,430.7 million by the end of 2035, growing at a CAGR of 7.5% from 2025 to 2035. The market growth is driven by the rising prevalence of uterine fibroids, increasing preference for minimally invasive procedures, and growing awareness about fertility-preserving surgical treatments.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86660

Market Overview

The myomectomy market is serving an increasing population of women with uterine fibroids, those growths of the uterus that may result in symptoms of abnormal heaviness of menses, pelvic pain, and loss of fertility. Myomectomy is a uterine-sparing surgery that provides a solution and is the procedure of choice among women seeking to retain reproductive capacity.

Three procedure types exist in the market: open myomectomy, laparoscopic myomectomy, and hysteroscopic myomectomy. Of these, open myomectomy has the widest use in those instances where large, multiple fibroids that extend into the muscle of the uterus are to be treated.

However, with innovation, unequal access to care and expensive procedures in emerging economies curtail uptake. Moreover, the selection of technique relies on age of the patient, size and site of the fibroids, surgeons’ experience and institutional capacity. Market majors are engaged in strategic alliances, product innovation and geographical expansion in order to build competitive advantage in this changing therapeutic space

 Analysts’ Viewpoint on the Global Myomectomy Market

The market for myomectomy is growing steadily with the increasing prevalence of uterine fibroids among women in the reproductive age group and the demand for uterus-sparing surgery. Myomectomy, to remove fibroids and preserve the uterus, is also favoured over hysterectomy to preserve fertility.

Open myomectomy continues to be the most dominant technique being used to treat multiple and large fibroids. Market growth is being driven by technological innovation in minimally invasive methods of myomectomy such as laparoscopic and robot-assisted myomectomy, though their use is hindered by cost and accessibility constraints.

 Analysis of Key Players in the Myomectomy Market

The market is led by diversified medical technology giants focusing on surgical energy and robotic platforms.

Leading companies include:

• Medtronic
• Stryker Corporation
• CONMED Corporation
• INSIGHTEC
• CooperSurgical Inc.
• Hologic, Inc.
• Intuitive Surgical
• Karl Storz
• B. Braun Melsungen AG
• Richard Wolf Medical Instruments
• Olympus Corporation
• Minerva Surgical Inc.
• Gynesonics

 Recent Developments in the Myomectomy Market

• In September 2024, Gynesonics Inc., announced the launch of its new SMART OS 2.4 software technology for the Sonata System. This system is designed for the minimally invasive treatment of symptomatic uterine fibroids. The Sonata System utilizes radiofrequency energy to ablate fibroids from within the uterus, eliminating the need for incisions. A key component is the SMART Guide, a proprietary technology that provides a graphical overlay on a live ultrasound image. This allows physicians to precisely target fibroids for ablation.
• In March 2024, Intuitive Surgical announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for their fifth-generation robotic system, the da Vinci 5. This marked a significant advancement in the field of minimally invasive surgery, building upon decades of Intuitive’s experience and millions of da Vinci procedures performed worldwide.

 👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=86660

Key Market Trends

• 🤖 AI-Enhanced Pre-Op Mapping: Using AI and MRI data to create 3D maps of fibroid locations, allowing surgeons to plan incisions that minimize uterine trauma.
• 🏥 Shift to ASCs: Ambulatory Surgical Centers (ASCs) are seeing a 6.8% CAGR in myomectomy volumes as advanced energy tools make outpatient laparoscopic surgery safer.
• 🧬 Single-Port Surgery: Growth in “scarless” surgery techniques where the entire procedure is performed through the belly button using specialized robotic arms.
• 🌡️ Energy-Driven Hemostasis: Widespread use of advanced bipolar sealers to reduce blood loss—a historical challenge in myomectomy.

Challenges & Opportunities

Challenges:

• Recurrence Rates: Up to 50% of patients may see new fibroid growth post-surgery, which can create a negative perception of the procedure’s long-term value.
• High Cost of Robotics: The initial capital investment for robotic systems remains a barrier in emerging economies and community hospitals.
• Skill Gap: Minimally invasive myomectomy is technically demanding, requiring extensive specialized training for gynecologists.

Opportunities:

• Emerging Markets (APAC): Rapidly expanding middle-class populations in China and India are driving a surge in elective, fertility-preserving surgeries.
• Post-Procedure Adhesion Barriers: A growing market for specialized sprays and films (like Interceed or Seprafilm) to prevent post-surgical scarring.
• Hybrid Procedures: Combining myomectomy with other treatments like uterine artery embolization (UAE) for comprehensive care.

Market Segmentation

➤ By Procedure Type

• Abdominal Myomectomy (Largest volume; used for complex cases)
• Laparoscopic Myomectomy (Highest value share)
• Robotic-Assisted Myomectomy (Fastest growth; 9.5% CAGR)
• Hysteroscopic Myomectomy (Focused on submucosal fibroids)

➤ By Product

• Laparoscopic Sealers & Harmonic Scalpels (Dominant; 40% share)
• Laparoscopic Power Morcellators (Regulated/Contained)
• Uterine Manipulators & Trocars

➤ By End-User

• Hospitals & Specialty Clinics (approx. 68% share)
• Ambulatory Surgical Centers (ASCs) (Fastest growing end-user)

➤ By Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Conclusion

The myomectomy market is no longer just a surgical niche; it is a critical component of modern reproductive health. By 2035, the integration of robotic precision and AI diagnostic mapping will make myomectomy a safer, more effective, and more accessible alternative to hysterectomy. For manufacturers, the goal is clear: provide tools that minimize blood loss and maximize uterine integrity to protect the future of maternal health.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=86660&ltype=S

More Trending Research Reports-

Sleep Apnea Devices Market – https://www.transparencymarketresearch.com/sleep-apnea-devices-market.html

Medical Devices Outsourcing Market – https://www.transparencymarketresearch.com/medical-devices-outsourcing-market.html

Microscopy Devices Market – https://www.transparencymarketresearch.com/microscopy-market.html

Autoinjectors Market – https://www.transparencymarketresearch.com/autoinjectors-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com